Congenital dyserythropoiesis and polymyopathy without cardiac disease in male Labrador retriever littermates. (5th July 2021)

• Record Type: Journal Article
• Authors: Thomas‐Hollands, Alison; Shelton, G. Diane; Guo, Ling T.; Loughran, Kerry; Kaiman, Gregory; A. Hutton, Tabitha; Walsh, Koranda A.
• Is Part Of: Journal of veterinary internal medicine. Volume 35:Number 5(2021)
• Page Start: 2409
• Page End: 2414
• Publication Date: 2021-07-05
• Subjects: anemia -- dyserythropoiesis -- metarubricytosis -- microcytosis -- muscle atrophy -- polymyopathy -- regurgitation; Veterinary medicine -- Periodicals; 636.0896
• DOI: 10.1111/jvim.16214
• Languages: English
• ISSNs: 0891-6640

Abstract

Abstract: Background: Two Labrador retriever littermates were identified based on incidentally noted marked microcytosis and inappropriate metarubricytosis. Muscle atrophy was noted and associated with distinctive pathological findings in biopsy samples from 1 dog studied. The disorder represents a rare clinical entity of suspected congenital dyserythropoiesis and polymyopathy. Clinicopathologic changes were similar to a previously reported syndrome of congenital dyserythropoiesis, congenital polymyopathy, and cardiac disease in 3 related English Springer Spaniel (ESS) dogs, but the dogs reported here did not have apparent cardiac disease. Interventions: Bone marrow aspiration, electromyography, muscle biopsies, and an echocardiogram were performed on dog 1. Results supported dyserythropoiesis and congenital polymyopathy similar to reports in ESS dogs, but did not identify obvious cardiac disease. Conclusion: The clinicopathologic changes of dyserythropoiesis and polymyopathy provide an easily recognizable phenotype for what appears to be a low morbidity syndrome. Early recognition may decrease unnecessary testing or euthanasia.